4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-20-064849
Chief Financial Officer sold 141,110 shares at an average $1.62 ($228,179)
- Chief Financial Officer acquired 141,110 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Moran Sean F. · Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-18 | Exercise or conversion : show line 1 in the form | +53,610 | $1.00 | $53,610 | 403,220 | D |
| 2020-12-18 | Sale : show line 2 in the form | −53,610 | $1.40 | $75,054 | 349,610 | D |
| 2020-12-21 | Exercise or conversion : show line 3 in the form | +87,500 | $1.40 | $122,500 | 437,110 | D |
| 2020-12-21 | Sale : show line 4 in the form | −87,500 | $1.75 | $153,125 | 349,610 | D |
| Open-market sales · 141,110 sh · avg $1.62 · $228,179 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2020-12-18 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −53,610 | $1.00 | $53,610 | $1.00 | 2024-04-11 | 53,610 | 53,610 | D |
| 2020-12-21 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −87,500 | $1.40 | $122,500 | $1.40 | 2026-01-07 | 87,500 | 87,500 | D |
Loading xslF345X03/doc4.xml…